MEDOCLAZIDE

This brand name is authorized in Cyprus, Malta, Singapore.

Active ingredients

The drug MEDOCLAZIDE contains one active pharmaceutical ingredient (API):

1	Gliclazide UNII G4PX8C4HKV - GLICLAZIDE
	Gliclazide is a hypoglycaemic sulfonylurea antidiabetic active substance. Gliclazide reduces blood glucose levels by stimulating insulin secretion from the β-cells of the islets of Langerhans.
	Read more about Gliclazide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MEDOCLAZIDE Tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BB09	Gliclazide	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BB Sulfonamides, urea derivatives
Discover more medicines within A10BB09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
MT	Medicines Authority	MA032/01901
SG	Health Sciences Authority	08423P